Zobrazeno 1 - 10
of 412
pro vyhledávání: '"Robert R, Redfield"'
Autor:
Eric J. Martinez, Phuoc H. Pham, Jesse F. Wang, Lily N. Stalter, Bridget M. Welch, Glen Leverson, Nicholas Marka, Talal Al-Qaoud, Didier Mandelbrot, Sandesh Parajuli, Hans W. Sollinger, Dixon B. Kaufman, Robert R. Redfield, Jon Scott Odorico
Publikováno v:
Transplant International, Vol 37 (2024)
Given the increasing frequency of simultaneous pancreas-kidney transplants performed in recipients with Type II diabetes and CKD, we sought to evaluate possible differences in the rates of allograft rejection, infection, and surgical complications in
Externí odkaz:
https://doaj.org/article/2589ad86da3a44ad825e193d7cef55b6
Publikováno v:
Antioxidants, Vol 13, Iss 6, p 642 (2024)
The limited supply and rising demand for kidney transplantation has led to the use of allografts more susceptible to ischemic reperfusion injury (IRI) and oxidative stress to expand the donor pool. Organ preservation and procurement techniques, such
Externí odkaz:
https://doaj.org/article/7bade70153d4404fb0e61d5e4b05a552
Autor:
Cary M. Looney, MS, Aaron Schroeder, BS, Erica Tavares, BSN, Jay Garg, MD, MBA, Thomas Schindler, PhD, Flavio Vincenti, MD, Robert R. Redfield, MD, Stanley C. Jordan, MD, Stephan Busque, MD, E. Steve Woodle, MD, Jared Khan, MS, Jeffrey Eastham, MS, Sandrine Micallef, PhD, Cary D. Austin, MD, PhD, Alyssa Morimoto, PhD
Publikováno v:
Transplantation Direct, Vol 9, Iss 2, p e1436 (2023)
Background. The THEORY study evaluated the effects of single and multiple doses of obinutuzumab, a type 2 anti-CD20 antibody that induces antibody-dependent cell-mediated cytotoxicity and direct cell death, in combination with standard of care in pat
Externí odkaz:
https://doaj.org/article/10259b2ed34f4a58b4712c88b2dfd5e4
Impact of low‐level pretransplant donor‐specific antibodies on outcomes after kidney transplantation
Autor:
Sandesh Parajuli, Natalie M. Bath, Luis Hidalgo, Glen Leverson, Neetika Garg, Robert R. Redfield III, Didier A. Mandelbrot
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1508-1519 (2021)
Abstract Background The effect of low‐level pretransplant donor‐specific antibody (DSA) on kidney transplant outcomes is not well described. The goal of this study was to compare outcomes among patients of varying immunologic risk, based on the l
Externí odkaz:
https://doaj.org/article/6d8e7127d34947fd8e3f06d8138864c9
Autor:
Sandesh Parajuli, Emily Joachim, Sayee Alagusundaramoorthy, Fahad Aziz, Justin Blazel, Neetika Garg, Brenda Muth, Maha Mohamed, Robert R. Redfield, Didier A. Mandelbrot, Weixiong Zhong, Arjang Djamali
Publikováno v:
Kidney International Reports, Vol 4, Iss 8, Pp 1057-1065 (2019)
Introduction: Donor-specific antibodies (DSAs) are considered an important risk factor for graft injury and failure. However, there is limited information on long-term outcomes for kidney transplant recipients with positive DSAs in the absence of rej
Externí odkaz:
https://doaj.org/article/d2e0fe1e63314a878e547c4306adfb1a
Autor:
Bret M. Verhoven, BS, Aos S. Karim, MD, Natalie M. Bath, MD, Carol J. Sarabia Fahl, MS, Nancy A. Wilson, PhD, Robert R. Redfield, III, MD, William E. Fahl, PhD
Publikováno v:
Transplantation Direct, Vol 6, Iss 8, p e578 (2020)
Background. Ischemia-reperfusion injury, including injury from warm- and cold-ischemia (CI) organ storage, remains a significant problem for all solid organ transplants. Suppressing CI damage would reduce delayed graft function and increase the donor
Externí odkaz:
https://doaj.org/article/3702a247a1fe464395149b7e4a13e8cd
Autor:
Natalie M Bath, Xiang Ding, Nancy A Wilson, Bret M Verhoven, Brittney A Boldt, Adarsh Sukhwal, Shannon R Reese, Sarah E Panzer, Arjang Djamali, Robert R Redfield
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211865 (2019)
Alloantibody represents a significant barrier in kidney transplant through the sensitization of patients prior to transplant through antibody mediated rejection (ABMR). APRIL BLyS are critical survival factors for mature B lymphocytes plasma cells, t
Externí odkaz:
https://doaj.org/article/029b107867da4ec9ba34a04f8fdd2243
Autor:
Natalie M Bath, Xiang Ding, Bret M Verhoven, Nancy A Wilson, Lauren Coons, Adarsh Sukhwal, Weixiong Zhong, Robert R Redfield Iii
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223889 (2019)
Chronic antibody mediated rejection (cAMR) remains a significant barrier to achieving long-term graft survival in kidney transplantation, which results from alloantibody production from B lymphocytes and plasma cells. APRIL (A proliferation-inducing
Externí odkaz:
https://doaj.org/article/14aeae110b9649bda5b3024ae64baff4
Autor:
Zijian Zhang, MD, Nancy A. Wilson, PhD, Raghavan Chinnadurai, PhD, Sarah E. Panzer, MD, Robert R. Redfield, III, MD, Shannon R. Reese, MS, Jacques Galipeau, MD, Arjang Djamali, MD
Publikováno v:
Transplantation Direct, Vol 4, Iss 9, p e387 (2018)
Background. We hypothesized that immunomodulatory properties of mesenchymal stromal cells (MSC) may be considered for desensitization. Methods. Autologous or allogeneic bone marrow derived MSC were infused via tail vein at 0.5 M (0.5 × 106), 1 M, or
Externí odkaz:
https://doaj.org/article/a7033284cd544c1e97cd70df9ace142d
Impact of low‐level pretransplant donor‐specific antibodies on outcomes after kidney transplantation
Autor:
Natalie M. Bath, Neetika Garg, Robert R. Redfield, Sandesh Parajuli, Glen Leverson, Didier A. Mandelbrot, Luis G. Hidalgo
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1508-1519 (2021)
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease
Background The effect of low‐level pretransplant donor‐specific antibody (DSA) on kidney transplant outcomes is not well described. The goal of this study was to compare outcomes among patients of varying immunologic risk, based on the level of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c209bcc8ff2557c50ca0ed9507975cd6
https://doaj.org/article/6d8e7127d34947fd8e3f06d8138864c9
https://doaj.org/article/6d8e7127d34947fd8e3f06d8138864c9